1. A phase II study of the combination of gemcitabine and imatinib mesylate in pemetrexed-pretreated patients with malignant pleural mesothelioma. (April 2020) Authors: Zucali, Paolo Andrea; Perrino, Matteo; De Vincenzo, Fabio; Giordano, Laura; Cordua, Nadia; D'Antonio, Federica; Santoro, Armando Journal: Lung cancer Issue: Volume 142(2020) Page Start: 132 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Advances in drug treatments for mesothelioma. (24th May 2022) Authors: Zucali, Paolo Andrea; De Vincenzo, Fabio; Perrino, Matteo; Digiacomo, Nunzio; Cordua, Nadia; D'Antonio, Federica; Borea, Federica; Fazio, Roberta; Pirozzi, Angelo; Santoro, Armando Journal: Expert opinion on pharmacotherapy Issue: Volume 23:Number 8(2022) Page Start: 929 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Avelumab plus axitinib in unresectable or metastatic type B3 thymomas and thymic carcinomas (CAVEATT): a single-arm, multicentre, phase 2 trial. Issue 10 (October 2022) Authors: Conforti, Fabio; Zucali, Paolo Andrea; Pala, Laura; Catania, Chiara; Bagnardi, Vincenzo; Sala, Isabella; Della Vigna, Paolo; Perrino, Matteo; Zagami, Paola; Corti, Chiara; Stucchi, Sara; Barberis, Massimo; Guerini-Rocco, Elena; Di Venosa, Benedetta; De Vincenzo, Fabio; Cordua, Nadia; Santoro, Arm... Journal: Lancet oncology Issue: Volume 23:Issue 10(2022) Page Start: 1287 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Best practices for the management of thymic epithelial tumors: A position paper by the Italian collaborative group for ThYmic MalignanciEs (TYME). (December 2018) Authors: Alloisio, Marco; Apolone, Giovanni; Ardizzoni, Andrea; Benvenuti, Mauro; Berruti, Alfredo; Breda, Cristiano; Buzzoni, Carlotta; Calabrese, Fiorella; Caraceni, Augusto; Cardillo, Giuseppe; Casadio, Caterina; Cassi, Elio; Caterino, Mauro; Cecere, Fabiana Letizia; Chiti, Arturo; Crippa, Arturo; Curc... Journal: Cancer treatment reviews Issue: Volume 71(2018) Page Start: 76 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Best practices for the management of thymic epithelial tumors: A position paper by the Italian collaborative group for ThYmic MalignanciEs (TYME). (December 2018) Authors: Imbimbo, Martina; Ottaviano, Margaret; Vitali, Milena; Fabbri, Alessandra; Leuzzi, Giovanni; Fiore, Michele; Franceschini, Davide; Pasello, Giulia; Perrino, Matteo; Schiavon, Marco; Pruneri, Giancarlo; Dei Tos, Angelo Paolo; Sangalli, Claudia; Garassino, Marina Chiara; Berardi, Rossana; Alessi, A... Journal: Cancer treatment reviews Issue: Volume 71(2018) Page Start: 76 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Checkpoint inhibitors as treatment for malignant gliomas: "A long way to the top". (September 2018) Authors: Simonelli, Matteo; Persico, Pasquale; Perrino, Matteo; Zucali, Paolo Andrea; Navarria, Pierina; Pessina, Federico; Scorsetti, Marta; Bello, Lorenzo; Santoro, Armando Journal: Cancer treatment reviews Issue: Volume 69(2018) Page Start: 121 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Continuous sunitinib schedule in advanced platinum refractory thymic epithelial neoplasms: A retrospective analysis from the ThYmic MalignanciEs (TYME) Italian collaborative group. (October 2022) Authors: Antonarelli, Gabriele; Corti, Chiara; Zucali, Paolo Andrea; Perrino, Matteo; Manglaviti, Sara; Lo Russo, Giuseppe; Varano, Gianluca Maria; Salvini, Piermario; Curigliano, Giuseppe; Catania, Chiara; Conforti, Fabio; De Pas, Tommaso Journal: European journal of cancer Issue: Volume 174(2022) Page Start: 31 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Gemcitabine with or without ramucirumab as second-line treatment for malignant pleural mesothelioma (RAMES): a randomised, double-blind, placebo-controlled, phase 2 trial. Issue 10 (October 2021) Authors: Pinto, Carmine; Zucali, Paolo Andrea; Pagano, Maria; Grosso, Federica; Pasello, Giulia; Garassino, Marina Chiara; Tiseo, Marcello; Soto Parra, Hector; Grossi, Francesco; Cappuzzo, Federico; de Marinis, Filippo; Pedrazzoli, Paolo; Bonomi, Maria; Gianoncelli, Letizia; Perrino, Matteo; Santoro, Arma... Journal: Lancet oncology Issue: Volume 22:Issue 10(2021) Page Start: 1438 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Hypofractionated radiation therapy (HFRT) versus conventional fractionated radiation therapy (CRT) for newly diagnosed glioblastoma patients. A propensity score matched analysis. Issue 1 (April 2018) Authors: Navarria, Pierina; Pessina, Federico; Franzese, Ciro; Tomatis, Stefano; Perrino, Matteo; Cozzi, Luca; Simonelli, Matteo; Bello, Lorenzo; Clerici, Elena; Riva, Marco; Santoro, Armando; Scorsetti, Marta Journal: Radiotherapy and oncology Issue: Volume 127:Issue 1(2018) Page Start: 108 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. In-vivo imaging of methionine metabolism in patients with suspected malignant pleural mesothelioma. Issue 11 (November 2019) Authors: Lopci, Egesta; Novellis, Pierluigi; Testori, Alberto; Rahal, Daoud; Voulaz, Emanuele; Bottoni, Edoardo; Ferraroli, Giorgio Maria; Crepaldi, Alessandro; Ceresoli, Giovanni Luca; Perrino, Matteo; Castello, Angelo; Alloisio, Marco; Veronesi, Giulia; Zucali, Paolo Andrea Journal: Nuclear medicine communications Issue: Volume 40:Issue 11(2019:Nov.) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗